#CVCT - Women As One joint session with impressive set of speakers and panalists this morning : Terri Cornelison (FDA, USA), Professor Vijay Kunadian, Angela Maas (Nijmegen, NED), Jaime Raben (FDA, USA), Lisa Flanigan Salberg (HCMA, USA), Harriette Van Spall, MD MPH, Orly Vardeny, Mary N. Walsh, Cindy Westerhout, PhD

Shall we make CVCT swag: bumper stickers !! #CVCT2023 Role of Real World Evidence in therapeutic effectiveness

Important considerations with RWD studies, courtesy of Stuart Pocock #CVCT2023

Wow! Super cool! #proteomicspower Great session on Biomarker Science for Clinical Trials #CVCT2023

We had a great meeting today in Washington at the #CVCT2023 conference on the importance of involvement of #Women as leaders AND patients in clinical trials ⁦Women As One⁩ ⁦CVCT - CardioVascular Clinical Trialists⁩ linkedin.com/posts/women-as…

Navigating legal and ethical framework in CV trials. #CVCT2023

All wrapped up for another year! An absolute gem of all meetings #CVCT2023

[SAVE THE DATE] Time to mark your calendars ! #CVCT2024 is coming your way December 9-11, 2024 ! Registrations open in June - stay tuned ! globalcvctforum.com #CardioTwitter #ClinicalResearch #clinicaltrials

Today we announced a new research chair in cardiovascular science in UAlberta Med & Dent that will help advance research and improve health outcomes for patients. The initiative is funded by a $5-million donation from the CVC Cardiovascular Health Foundation

Today marks a significant milestone in our journey toward advancing cardiovascular care & research for our patients. Thank you, Canadian VIGOUR Centre Cardiovascular Health Foundation, for your generous gift of $5M to create an Endowed Chair bit.ly/4afDhYg

A new research chair in cardiovascular science, funded by the CVC Cardiovascular Health Foundation, will help drive advancements in cardiovascular research at the U of A. Read the story: bit.ly/48ZMC5l

Ready for #ACC24! ❤️

Great job Javed Butler on the EMPACT-mi trial presentation representing a global community This trial was such an incredible journey starting at beginning of the pandemic and getting done through regional wars. What a team effort! Schuyler Jones Duke Clinical Research Institute Canadian VIGOUR Centre

Yay for puppies! #ACC24

Wrapping up #ACC24 posts with 🤳 by my incredible Duke Clinical Research Institute mentor Robert Mentz, MD! Also special thanks to Dr. Armstrong for his guidance on this VICTORIA analysis! Trend of ⬆️ effects of vericiguat in lower-risk pts simulated from PARADIGM-HF/DAPA-HF. More to learn from VICTOR!

Latest evidence of utter failure of non-inferiority trials to set appropriate non-inferiority margins. Clinicians should ignore these margins & statistical claims of non-inferiority & instead think how their patients would balance benefits/harms/burdens. pubmed.ncbi.nlm.nih.gov/37421996/

Using #QualityOfLife adjusted Days Alive and Out of Hospital in #ClinicalTrials may provide complementary information to traditional outcome metrics Justin Ezekowitz Pishoy Gouda Canadian VIGOUR Centre Michael Felker Heather Ross Christopher O'Connor #AHAJournals ahajournals.org/doi/10.1161/CI…

Proud to have partnered with patients, PHA Canada and Canadian VIGOUR Centre on this important project.

Want to know what SPOR is all about? Join us for Grand Rounds June 21st: Alberta SPOR SUPPORT Unit: What We Can Do For You Our Research Services, Training Programs, and Impacts. Register here: shorturl.at/zRzXR

Great Times gathering with our Canadian collaborators, friends and family who we’ve partnered with in #clinicaltrials for over 25 years Here’s to future success improving #cardiovascular health with Canadian VIGOUR Centre